Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: A Study of Colesevelam in Fecal Incontinence [Phase 3]

View source ↗

Summary

Phase 3 trial of colesevelam in fecal incontinence and bile acid malabsorption has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colesevelam (colesevelam)

Snippet

Sponsor: Mayo Clinic | Conditions: Fecal Incontinence, Bile Acid Malabsorption | Phase 3 | Status: COMPLETED | Results posted: 2023-06-22